Harrison Douglas

10PUBLICATIONS
71CO-AUTHORS
Molecular targetsCultural responsiveness and working with Pacific Peoples communities educationRadiation therapyPredictive and prognostic markersToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 10, 2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma Models.

Yifei Wang, Zhongting Zhang, Caterina Longo

|Nov 21, 2025
In-Person and Virtual Adaptation of an Interprofessional Palliative Care Communications Skills Training Course for Pediatric Oncology Clinicians.

Karen M Moody, Clark R Andersen, Robert M Arnold

|Apr 17, 2024
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.

Jonathan Metts, Wei Xue, Zhengya Gao

|Jan 28, 2024
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Douglas J Harrison, Amira Qumseya, Wei Xue

|Apr 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).

Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik

|Oct 17, 2022
Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma.

Douglas Harrison, Jonathan Gill, Michael Roth

Pageof 2

Frequent Collaborators

4 joint publications

Jonathan Gill

2 joint publications

Michael Roth

2 joint publications

Aaron R Weiss

2 joint publications

Richard Gorlick